Home › Hypertrophic Cardiomyopathy › New York › New York City
Hypertrophic Cardiomyopathy clinical trials in New York City, NY
3 studies for Hypertrophic Cardiomyopathy are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
RecruitingObservational study
- Mount Sinai Hospital, New York
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
RecruitingObservational studyHealthy volunteers welcome
- Columbia University Irving Medical Center, New York
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
RecruitingPhase 2
- Imbria Investigational Site, New York
Hypertrophic Cardiomyopathy trials in other cities
- Boston, MA6 studies
- Cleveland, OH4 studies
- Charlottesville, VA4 studies
- San Francisco, CA4 studies
- Chicago, IL3 studies
- Plano, TX3 studies
- Charlotte, NC3 studies
- Houston, TX3 studies
- San Diego, CA3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.